Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Total Voting Rights

30 Apr 2021 17:00

RNS Number : 2273X
Braveheart Investment Group plc
30 April 2021
 

30 April 2021

Braveheart Investment Group plc

("Braveheart" or "the Company")

 

Total Voting Rights

 

Braveheart Investment Group (AIM: BRH) announces that, following the issue of 10,000 ordinary shares on exercise of options under the block listing, the issued share capital of the Company at the date of this announcement comprises of 38,307,451 ordinary shares of 2p each ("Ordinary Shares"), with one voting right per share. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 38,307,451.

 

The figure of 38,307,451 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information: 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREANLEDDDFEEA
Date   Source Headline
11th Aug 200810:26 amRNSEPT Disclosure
28th Jul 20087:00 amRNSGrant of Options
18th Jul 20083:09 pmRNSResponse RE Angle Offer
18th Jul 20087:00 amRNSStatement re possible offer
16th Jul 20089:17 amRNSEPT Disclosure
11th Jul 20081:05 pmRNSStatement re. announcement
11th Jul 20088:10 amRNSOffer Update
25th Jun 20087:00 amRNSPreliminary Results
23rd Jun 20081:58 pmRNSFurther re notice of results
23rd Jun 20087:01 amRNSCommercialisation Agreement
23rd Jun 20087:00 amRNSInvestment in IM-Sense
16th Jun 20087:00 amRNSNotice of Results
13th Jun 200812:27 pmRNSErnst and Young Award
5th Jun 20087:00 amRNSDirectorate Change
14th Apr 20087:00 amRNSInvestment in Spiral Gateway
10th Apr 200811:15 amRNSFurther re possible offer
10th Apr 20087:00 amRNSInvestment in Cascade
9th Apr 20084:24 pmRNSPossible Offer
7th Apr 20087:00 amRNSInvestment In Conjunct
2nd Apr 20087:01 amRNSInvestment in AppShare
13th Feb 20087:00 amRNSInvestment
8th Feb 20087:00 amRNSChange of Adviser
10th Jan 20087:00 amRNSInvestment
2nd Jan 20083:38 pmRNSChange of Adviser
3rd Dec 20077:00 amRNSInterim Results
21st Nov 20078:43 amRNSNotice of Results
1st Oct 20077:01 amRNSPortfolio Company Update
13th Sep 20077:05 amRNSResult of AGM
13th Sep 20077:01 amRNSDirectorate Change
20th Aug 20077:00 amRNSInvestment
17th Aug 20077:00 amRNSNotice of AGM/Annual Report
14th Aug 20077:00 amRNSAIM Rule 26
13th Aug 20077:00 amRNSInvestment
13th Jul 20077:00 amRNSAward of Options
19th Jun 20077:01 amRNSInvestment
18th Jun 20077:01 amRNSFinal Results
18th Jun 20077:00 amRNSFund Launch
14th Jun 20077:01 amRNSInvestment
8th Jun 20077:15 amRNSNotice of Results
4th Jun 200710:44 amRNSInvestee company flotation
3rd May 20077:01 amRNSInvestment
5th Apr 20071:06 pmRNSHolding(s) in Company
5th Apr 20077:01 amRNSAcquisition
4th Apr 20078:00 amRNSHolding(s) in Company
3rd Apr 20077:01 amRNSInvestment into EctoPharma
30th Mar 20077:01 amRNSDealings Commence

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.